HeartBeam (NASDAQ:BEATW – Get Free Report) is projected to post its results after the market closes on Thursday, November 5th. Analysts expect HeartBeam to announce earnings of ($0.09) per share and revenue of $0.07 million for the quarter.
HeartBeam Stock Up 11.8%
Shares of NASDAQ:BEATW opened at $0.01 on Thursday. The company has a 50 day moving average of $0.01 and a 200-day moving average of $0.07. HeartBeam has a twelve month low of $0.00 and a twelve month high of $0.56.
About HeartBeam
HeartBeam, Inc is a medical technology company developing portable, patient-directed cardiac monitoring solutions. The company’s platform is designed to capture and transmit electrocardiogram (ECG) data outside traditional clinical settings, supporting the evaluation of symptoms such as palpitations and irregular heart rhythms.
HeartBeam’s principal product is the AIMIGo system, a compact, cable-free device intended to record a three-dimensional, 12-lead-equivalent ECG. The system works with a smartphone application and related software to help users collect cardiac data and share it with healthcare professionals for review.
See Also
- Five stocks we like better than HeartBeam
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for HeartBeam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartBeam and related companies with MarketBeat.com's FREE daily email newsletter.
